What companies are 6744.TWO's competitors?

Feng Chi Biotech Corp. (6744.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 6744.TWO compare to its peers?

The peer comparison table on this page shows Feng Chi Biotech Corp. (6744.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 6744.TWO operate in?

Feng Chi Biotech Corp. (6744.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6744.TWO

Feng Chi Biotech Corp.

TWO·Biotechnology · Healthcare

NT$14.20NT$0.10−0.70%

Market capNT$218.68M·Market closed·Aug 28 3:31 AM UTC

Frequently Asked Questions About 6744.TWO

What companies are 6744.TWO's competitors?: Feng Chi Biotech Corp. (6744.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6744.TWO compare to its peers?: The peer comparison table on this page shows Feng Chi Biotech Corp. (6744.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6744.TWO operate in?: Feng Chi Biotech Corp. (6744.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

6744.TWO

Feng Chi Biotech Corp.

TWO·Biotechnology · Healthcare

NT$14.20NT$0.10−0.70%

Market capNT$218.68M·Market closed·Aug 28 3:31 AM UTC

Peers


6662.TWO	BioLASCO Taiwan Co., Ltd.	NT$29.75	NT$762.0M
4170.TWO	Vectorite Biomedical Inc.	NT$12.70	NT$555.9M
6549.TWO	TaiwanJ Pharmaceuticals Co., Ltd.	NT$6.90	NT$552.8M
7607.TWO	DuoGenic StemCells corporation	NT$11.85	NT$434.3M
6621.TWO	UniPharma Co., Ltd.	NT$11.45	NT$412.6M
6661.TWO	Welgene Biotech Co.,Ltd.	NT$16.40	NT$382.2M
6848.TWO	RBC Bioscience Corporation	NT$24.15	NT$344.7M
4183.TWO	EPS Bio Technology Corp.	NT$14.00	NT$333.2M
4197.TWO	Visgeneer Inc.	NT$8.57	NT$258.7M
6734.TWO	iXensor Co., Ltd.	NT$6.00	NT$249.2M

Frequently Asked Questions About 6744.TWO

What companies are 6744.TWO's competitors?: Feng Chi Biotech Corp. (6744.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 6744.TWO compare to its peers?: The peer comparison table on this page shows Feng Chi Biotech Corp. (6744.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 6744.TWO operate in?: Feng Chi Biotech Corp. (6744.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.